Effect of Cabergoline on Endometrial Vascularity During IntraCytoplasmic Sperm Injection
Effect of Cabergoline on Subendometrial Vascularity During ICSI Cycles and Pregnancy Outcome
Sponsor: Kasr El Aini Hospital
Listed as NCT02306564, this PHASE2/PHASE3 trial focuses on Infertility and remains ongoing. Sponsored by Kasr El Aini Hospital, it has been updated 7 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE2/PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2/PHASE3
Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE2_PHASE3
-
Jan 2019 — Jan 2021 [monthly]
Unknown Status PHASE2_PHASE3
Status: Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2019 [monthly]
Recruiting PHASE2_PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE2_PHASE3
First recorded
Dec 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Kasr El Aini Hospital
For direct contact, visit the study record on ClinicalTrials.gov .